We are live on
!
Find out more
SCG
Social Capital Group Portfolio holdings
AUM
$5.16M
1-Year Est. Return
66.85%
This Quarter
Est. Return
-11.26%
1 Year Est. Return
-66.85%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.78M
AUM Growth
-$53.7M
(-90%)
Cap. Flow
-$53M
Cap. Flow
% of AUM
-916.69%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProKidney
PROK
|
+$53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKLI
1
DELISTED
Akili Inc
AKLI
| $5.78M | 100% |
11,873,000
| – | – |
|
|
2
ProKidney
PROK
$380M
| – | – |
-11,573,000
| Closed | -$53M |
|
Similar funds
TM
APGC
APA
AI
KSCM
SP
EL
T
Social Capital Group's Q4 2023 Portfolio in Review
As of Q4 2023, Social Capital Group held 2 positions worth $5.78M, down 90% from $59.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Social Capital Group withdrew a net $53M in Q4 2023, closing 1 position. Its most notable exit was ProKidney, an estimated $53M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Social Capital Group fully exited ProKidney in Q4 2023, selling an estimated $53M.
- Social Capital Group's ten largest holdings make up 100% of its $5.78M portfolio in Q4 2023.
- Social Capital Group opened 0 new positions and closed 1 in Q4 2023.
- Social Capital Group's portfolio value fell 90% quarter-over-quarter to $5.78M.
Based on Social Capital Group's 13F filing for Q4 2023, filed 9 Feb 2024.